MTD vs SUPN · P/E 27, rev $3.87B vs rev $661.8M
Mettler-Toledo International Inc (MTD) versus Supernus Pharmaceuticals Inc (SUPN) — a side-by-side from cached financials, not a winner call.
Mettler-Toledo International Inc (MTD) is a diagnostics & research company listed on NYSE.
Supernus Pharmaceuticals Inc (SUPN) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported MTD revenue for 2024-12-31 was $3.87B. Net income was $863.1M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
Latest reported SUPN revenue for 2024-12-31 was $661.8M. Net income was $73.9M. Revenue was up 8.9% from 2023-12-31 to 2024-12-31. SUPN currently screens at market cap $2.53B.
MTD currently screens at market cap $23.20B and trailing P/E 26.9. SUPN currently screens at market cap $2.53B.
Not investment advice. Open the MTD and SUPN stock pages for the full models.
Not investment advice.